MEG Election Results

Congratulations to Ellen L. Goode, PhD, MEG Chairperson-elect 2017-2018

Our thanks to Peter Kraft, PhD, and Ellen L. Goode, PhD, MPH, for standing for election, and to the MEG membership for participating in the election. We congratulate Dr. Goode on her election as MEG Chairperson-elect. Dr. Goode will assume the office of Chairperson-elect at the AACR Annual Meeting 2017, April 1-5, 2017, in Washington, D.C.

Ellen L. Goode, PhD, MPH
Professor of Epidemiology
Department of Health Sciences Research
Mayo Clinic College of Medicine
Rochester, Minnesota

PhD, University of Washington, Seattle, Washington
MPH, University of California, Berkeley, California

Research Interests:
I oversee an extensive research program in cancer genetic epidemiology at the Mayo Clinic involving numerous collaborations. My primary interest is in ovarian cancer, yet I also play a role in studies of other gynecologic and Lynch syndrome cancers. My background is in family-based studies, and recent work seeks to identify and characterize inherited loci associated with risk and outcome, utilizing large sample sizes and integrating data types such as sequence, methylation and expression. I serve on oversight committees of several groups and am passionate about applying novel statistical approaches to best increase understanding of cancer etiology and progression.

Proposed Goals:
Since its inception, MEG has provided a strong and supportive community within the vastness that is AACR. Our special conferences have been top-notch and consistently predictive of research trends, and our annual Town Hall provides outstanding connecting opportunities for junior and senior scientists alike.

As MEG Chairperson-elect, I aim to increase our membership and visibility within the organization. I also would like to forge deeper connections with the AACR association groups, such as Women in Cancer Research (WICR), Minorities in Cancer Research (MICR), and the Associate Member Council (AMC). Members would benefit from the further compilation of grant-writing resources and a greater focus on international opportunities. AACR is clearly international.

Let’s drive our scientific content, even more so than now, to push boundaries in multidisciplinary research. We are epidemiologists, thus, adept at bringing together multiple disciplines; but we are also more. We are motivated scientists in clinical care, biostatistics, bioinformatics, screening, systems biology, and other areas. We are increasingly also investigators uniquely trained in multidisciplinary research. How can we best work together to fight cancer? Based on our past successes and the support that AACR shows MEG, we have many mechanisms with which to address this question.

AACR can do this, and MEG can lead the way.